 |
 |

Clinical Aspects of Genetic Variability in Helicobacter pylori
Stuart Jon Spechler, MD;
Lori Fischbach, PhD;
Mark Feldman, MD
JAMA. 2000;283:1264-1266.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
INTRODUCTION
Helicobacter Pylori organisms have been infecting human stomachs for centuries. Antigens of these microaerophilic, gram-negative bacteria have been found in stool samples of ancient mummies.1 Today, it appears that more than half of the world's population is infected with H pylori.2 These organisms are adapted for survival in the stomach in which infection causes a chronic gastritis that persists for decades.
H pylori infection is strongly associated with peptic ulcer disease, and is widely accepted as a risk factor for gastric adenocarcinoma and mucosa-associated lymphoid tissue (MALT) lymphoma.3 Antibiotic therapy aimed at eradicating H pylori is recommended for infected patients who have verified peptic ulcerations of the stomach or duodenum, or who have gastric MALT lymphomas.4 Nevertheless, it has been estimated that less than 20% of individuals who are chronically infected with H pylori ever develop a peptic ulcer . . . [Full Text of this Article]
Genetic Variability and Virulence
Clinical and Epidemiological Aspects of CagA Positivity
Current Recommendations and Directions for Future Research
Author Affilations: Department of Veterans Affairs Medical Center, Dallas (Drs Spechler and Feldman), University of Texas Southwestern Medical Center (Drs Spechler, Fischbach, and Feldman), School of Public Health (Dr Fischbach); and the University of Texas Health Science Center, Houston (Dr Fischbach).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED ARTICLE
March 8, 2000
JAMA. 2000;283(10):1361-1362.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Concepts in the Prevention of Adenocarcinoma of the Distal Esophagus and Proximal Stomach
Souza and Spechler
CA Cancer J Clin 2005;55:334-351.
ABSTRACT
| FULL TEXT
|